Skip to content

Veracyte VCYT Net Income

Net Income at other companies

Guardant Health logo
Guardant HealthGH
-$112.08M-17.8%
Natera, Inc. logo
Natera, Inc.NTRA
-$85.09M-27.1%
Revvity logo
RevvityRVTY
$40.72M-3.6%
Labcorp Holdings logo
Labcorp HoldingsLH
$277.8M+30.5%
Quest Diagnostics logo
Quest DiagnosticsDGX
$252M+14.5%
Agilent Technologies logo
Agilent TechnologiesA
$339M+57.7%

Segments

By segment

See full
Reportable Segment$28.71M+307%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.28B+10.7%
Enterprise value$4.05B+7.4%
P/E48.6×-68.3×
P/S7.9×-0.4×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's net income?
Veracyte (VCYT) reported net income of $28.71M in Q1 2026.
How has Veracyte's net income changed year-over-year?
Veracyte's net income increased by 307.4% year-over-year, from $7.05M to $28.71M.
What is the long-term trend for Veracyte's net income?
Over 4 years (2021 to 2025), Veracyte's net income has grown at a -3.2% compound annual growth rate (CAGR), from -$75.56M to $66.35M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.